✦ LIBER ✦

Phase II Trial of Pyrazoloacridine in Patients with Persistent or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

✍ Scribed by Steven C. Plaxe; John A. Blessing; Nader Husseinzadeh; Kenneth D. Webster; Janet S. Rader; Charles J. Dunton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Topotecan in Patient

✍ David Scott Miller; John A. Blessing; Samuel S. Lentz; Steven E. Waggoner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II trial of danazol in advanced, r

✍ Allan Covens; Virginia L Brunetto; Maurie Markman; James W Orr Jr.; Samuel S Len 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Phase II Trial of Pyrazoloacridine in Re

✍ Steven C. Plaxe; John A. Blessing; Michael A. Bookman; William T. Creasman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Dactinomycin in the Treatment of Recurre

✍ David H. Moore; John A. Blessing; Charles Dunton; Richard E. Buller; Gary C. Rei 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Phase II trial of combination bevacizuma

✍ E. Alvarez; W. Brady; J. Walker; J. Rotmensch; X. Zhou; J. Kendrick; S. Yamada; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB